The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling

B S Muhlhausler1, J A Duffield, S E Ozanne

  • 1Early Origins of Adult Health Research Group, Sansom Research Institute, University of South Australia, Adelaide 5001, Australia.

Insights

Small birth size and rapid postnatal growth are linked to insulin resistance. This study found fetal growth restriction increases insulin receptors in muscle, promoting accelerated growth post-birth.

Area of Science:

  • Perinatal programming
  • Metabolic adaptation
  • Developmental origins of health and disease

Background:

  • Epidemiological studies link small birth size and rapid postnatal growth to adult insulin resistance.
  • Understanding the mechanisms behind accelerated postnatal growth after in utero growth restriction is crucial.

Purpose of the Study:

  • To investigate the molecular basis for accelerated postnatal growth in lambs with intrauterine growth restriction.
  • To examine insulin and IGF1 receptor protein abundance and insulin signaling molecules in muscle.

Main Methods:

  • Quadriceps muscle samples collected from fetal and newborn lambs.
  • Comparison between normally grown (Control) and placentally restricted (PR) lambs.
  • Analysis of insulin receptor, IGF1 receptor, PKC, PI3Kinase p85, Akt1, Akt2, and GLUT4 protein abundance.

Main Results:

  • PR fetuses showed higher insulin and IGF1 receptor abundance but lower PKC and GLUT4.
  • At 21 days postnatal, PR lambs maintained higher insulin receptor levels.
  • Upregulation of PI3Kinase p85, Akt1, Akt2, and GLUT4 was observed in PR lambs post-birth.

Conclusions:

  • Fetal growth restriction leads to increased insulin receptor abundance in skeletal muscle.
  • This increase persists post-birth, associated with upregulated insulin signaling and glucose transporter GLUT4.
  • These adaptations in the fetus may explain accelerated postnatal growth in response to restricted placental supply.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...